Biologics Contract Development Market to Expand at a CAGR of 7.3% by 2032

Rising demand biologics and requirement for contract development services outsourcing are major factors driving market revenue growth.

A detailed analysis of the Global Biologics Contract Development Market 2023 is provided, including global, regional, and country-level market sizes, segmentation market growth, market share, competitive landscape, sales analysis, impact of domestic and global Biologics Contract Development Market players, value chain optimization, trade regulations, recent developments, strategic market growth analyses, product launches, expanding the area market, and technological advances.


An analysis of Biologics Contract Development's growth rate, market share, market size, current and emerging trends, production and consumption ratios, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players is provided in the report, which has been segmented into key regions globally. This report provides a country-by-country analysis of the Biologics Contract Development market to give a clearer picture of its regional distribution and growth.

Request a sample Report of Biologics Contract Development Market @

Market Overview:


The global biologics contract development market size was valued at USD 10.19 billion in 2022 and is expected to reach USD 19.21 billion by 2032, and register a revenue CAGR of 7.3% during the forecast period. Rising demand biologics and requirement for contract development services outsourcing are major factors driving market revenue growth.

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Key Players covered in this report are -

  • Lonza Group AG
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Boehringer Ingelheim International GmbH
  • Samsung Biologics
  • WuXi Biologics
  • AbbVie Inc.
  • Pfizer Inc.
  • Merck Co., Inc.
  • Charles River Laboratories International, Inc.


Based on Product Type market is segmented into -

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Others


Based on Service Type market is segmented into -

  • Discovery
  • Preclinical
  • Clinical
  • Manufacturing


Based on Region market is segmented into –


  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East Africa


To know more about the latest insights of the report, visit @


Major Points covered in this report are as below:

  • An analysis of Biologics Contract Development industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.


  • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.


  • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.


  • This report provides information on the market status of Biologics Contract Development manufacturers and provides valuable insight into the market for companies and individuals.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa.


Request a customized copy of the report @


Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  


About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.


John W, Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs

Browse for more reports…

Kamal Kulkarni

51 Blog posts